MARKET

NVS

NVS

Novartis
NYSE
105.22
-0.52
-0.49%
After Hours: 105.13 -0.09 -0.09% 16:01 06/21 EDT
OPEN
105.39
PREV CLOSE
105.74
HIGH
105.71
LOW
104.44
VOLUME
1.30M
TURNOVER
0
52 WEEK HIGH
108.78
52 WEEK LOW
88.83
MARKET CAP
214.69B
P/E (TTM)
14.32
1D
5D
1M
3M
1Y
5Y
11 Sleep Well At Night Blue-Chip Bargains For Today's Overvalued Market
Since the October lows, stocks have been on fire, up 34%. Even with the market at an all-time high, there are extraordinary blue-chip bargains to buy. The best time to buy stocks is today. A high-yield dividend portfolio of 11 companies has delivered 17% total returns and 15% average bear market declines.
Seeking Alpha · 2h ago
UPDATE 2-Sarepta surges as investors cheer expanded use of gene therapy
Sarepta Therapeutics shares surge as much as 40% to a more than three-year high. U.S. FDA granted expanded use approval for company's gene therapy for Duchenne muscular dystrophy. Stock was set to add $4 billion to the company's market value.
Reuters · 23h ago
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
Nestle SA unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss medications. The company will not mention the weight loss drugs on the packaging. The European food giant said the company will be marketed through social media to avoid regulatory issues.
Benzinga · 1d ago
What's Going On With Neurological Disease Focused Trevena On Thursday?
Trevena Inc (NASDAQ:TRVN) released preclinical data from two separate research collaborations. The company's TRV045 is a novel S1P1 receptor modulator. The drug is being developed to treat chemotherapy-induced peripheral neuropathy. The stock is trading lower on Thursday.
Benzinga · 1d ago
Here's Why Novartis (NVS) is a Strong Momentum Stock
NASDAQ · 1d ago
Novartis intends to implement merger squeeze-out of MorphoSys minority shareholders
Seeking Alpha · 2d ago
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
NASDAQ · 2d ago
Eli Lilly: The Party Is Probably Nearing The End
Seeking Alpha · 2d ago
More
About NVS
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Webull offers Novartis AG (ADR) stock information, including NYSE: NVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVS stock methods without spending real money on the virtual paper trading platform.